Evidence map›Paper›PMID 37071400›Full record

ArticleVector borne and zoonotic diseases (Larchmont, N.Y.)2023

Incidence of Lyme Borreliosis in Finland: Exploring Observed Trends Over Time Using Public Surveillance Data, 2015-2020.

Jozica Skufca, Nick De Smedt, Andreas Pilz, Andrew Vyse, Elizabeth Begier, Maxim Blum, Margarita Riera, Bradford D Gessner, James H Stark

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vector borne and zoonotic diseases (Larchmont, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jozica SkufcaEpidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium.
Nick De SmedtEpidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium.
Andreas PilzVaccines, Pfizer Corporation Austria, Wien, Vienna, Austria.
Andrew VyseVaccines Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, United Kingdom.
Elizabeth BegierVaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA.
Maxim BlumEpidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium.
Margarita RieraEpidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium.
Bradford D GessnerVaccines Medical Development and Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
James H StarkVaccines Medical Development and Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Communicable DiseasesLyme DiseaseTick-Borne DiseasesAnimalsFinlandIncidenceFinlandincidenceLyme borreliosisspatial epidemiologysurveillancetick-borne disease

Identifiers

PMID37071400
PMCPMC10122252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.